Term Name: | EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase) inhibitor |
---|---|
Synonyms: | CYP3A4 inhibitor, CYP3A4 inhibitors, CYP4A21 inhibitor, CYP4A21 inhibitors, cytochrome P450 3A4 inhibitor, cytochrome P450 3A4 inhibitors, EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase) inhibitors, EC 1.14.13.97 inhibitor, EC 1.14.13.97 inhibitors, taurochenodeoxycholate 6alpha-hydroxylase inhibitor, taurochenodeoxycholate 6alpha-hydroxylase inhibitors, taurochenodeoxycholate 6alpha-monooxygenase inhibitor, taurochenodeoxycholate 6alpha-monooxygenase inhibitors, taurochenodeoxycholate,NADPH:oxygen oxidoreductase (6alpha-hydroxylating) inhibitor, taurochenodeoxycholate,NADPH:oxygen oxidoreductase (6alpha-hydroxylating) inhibitors |
Definition: | An EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor that interferes with the action of EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase). |
Ontology: | ChEBI [CHEBI:86501] ( EBI ) |